Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ota Fuchs

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|May 24, 2018
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory DrugsOta Fuchs
Leukemia Research and Treatment|December 6, 2012
Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathwayOta Fuchs
Current Molecular Pharmacology|July 3, 2010
Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignanciesOta Fuchs
Cardiovascular & Hematological Disorders Drug Targets|March 29, 2013
Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myelomaOta Fuchs
Blood Reviews|August 6, 2022
Targeting cereblon in hematologic malignanciesOta Fuchs
Polish Archives of Internal Medicine|July 7, 2017
Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib‑based therapyOta Fuchs
Cardiovascular & Hematological Disorders Drug Targets|March 10, 2021
Preclinical Studies of PROTACs in Hematological MalignanciesOta Fuchs, Radka Bokorova
Journal of Biochemical and Biophysical Methods|August 14, 2003
Native electrophoretic separation and femtomolar detection of 65Zn-containing proteins by storage phosphorimagingDaniel Vyoral, Marek Babusiak, Ota Fuchs, et al.
Cardiovascular & Hematological Disorders Drug Targets|March 12, 2009
Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cellsOta Fuchs, Dana Provaznikova, Iuri Marinov, et al.
International Journal of Molecular Sciences|June 13, 2019
High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant <i>NPM1</i> and <i>FLT3</i> MutationsBarbora Brodská, Petra Otevřelová, Cyril Šálek, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cardiovascular & Hematological Disorders Drug Targets|May 24, 2018
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory DrugsOta Fuchs
Leukemia Research and Treatment|December 6, 2012
Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathwayOta Fuchs
Current Molecular Pharmacology|July 3, 2010
Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignanciesOta Fuchs
Cardiovascular & Hematological Disorders Drug Targets|March 29, 2013
Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myelomaOta Fuchs
Blood Reviews|August 6, 2022
Targeting cereblon in hematologic malignanciesOta Fuchs
Polish Archives of Internal Medicine|July 7, 2017
Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib‑based therapyOta Fuchs
Cardiovascular & Hematological Disorders Drug Targets|March 10, 2021
Preclinical Studies of PROTACs in Hematological MalignanciesOta Fuchs, Radka Bokorova
Journal of Biochemical and Biophysical Methods|August 14, 2003
Native electrophoretic separation and femtomolar detection of 65Zn-containing proteins by storage phosphorimagingDaniel Vyoral, Marek Babusiak, Ota Fuchs, et al.
Cardiovascular & Hematological Disorders Drug Targets|March 12, 2009
Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cellsOta Fuchs, Dana Provaznikova, Iuri Marinov, et al.
International Journal of Molecular Sciences|June 13, 2019
High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant <i>NPM1</i> and <i>FLT3</i> MutationsBarbora Brodská, Petra Otevřelová, Cyril Šálek, et al.
Pageof 3